Compagnie Lombard Odier S Cm A Invitae Corp Transaction History

Compagnie Lombard Odier S Cm A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$6.28 - $15.59 $15,951 - $39,598	-2,540 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$24.31 - $33.6 $48,620 - $67,200	-2,000 Reduced 44.05%	2,540 $72,000
Q2 2021 Jul 15, 2021	SELL	$26.09 - $40.4 $7.84 Million - $12.1 Million	-300,406 Reduced 98.51%	4,540 $153,000
Q1 2021 Apr 23, 2021	BUY	$33.06 - $56.93 $10.1 Million - $17.4 Million	304,946 New	304,946 $11.7 Million
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $0 - $0	0 New	0 $0

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.